Inactivating mutations in large B-cell lymphoma in a real-world cohort: Strong correlation with translocation.

Inactivating mutations in Bruton's tyrosine kinase () in patients with follicular lymphoma (FL) have recently been reported. These mutations were found in BTK inhibitor-treatment naïve patients. Here, we report the mutation status in a real-world cohort of patients with non-Hodgkin lymphoma.